MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

Working together to improve surgery for both patients and surgeons

OUR VISION

Working in partnership with surgeons, we create, develop, and distribute innovative surgical products. At Biom’up, we are dedicated to optimizing surgery with a double objective: to boost surgeons performances and improve patients well-being.

OUR KNOW-HOW

HEMOBLAST™ Bellows is the result of more than a decade of expertise in the design, development, and delivery of collagen-based high-performing solutions for surgery.
We are developing a new generation of hemostatic products for use in a wide range of surgical specialties, including orthopedics, spine, cardiothoracic, general, maxillofacial ,and dental surgery.
Biom’up has already created several collagen-based products (COVA™, MATRI™ BONE), that have paved the way for the development of the first active hemostatic powder.

2005

Creation of 

2006
2011

Development and launch of medical devices for biosurgery that are used in a wide range of surgical specialties. Visit Biom’up website to learn more

2012

marking and launch of the HEMOSNOW™ range (collagen-based hemostatic powder)

2015
  • Biom’up announces authorization by the  to start the IDE clinical pilot study of HEMOBLAST™ Bellows
  • The launch of this trial confirms the hemostasis expertise of Biom’up
2016
  • Completion of pilot study (n=27)
  • FDA approves the IDE for the start of the pivotal clinical study for HEMOBLAST™ Bellows
  • Began Phase III controlled, prospective, randomized, multicenter trial, assessing the efficacy and safety of HEMOBLAST™ Bellows in cardiac, abdominal, and spine surgery
  • Interim analysis after inclusion of half of the population: all endpoints already reached
2017
  • Completion of the pivotal clinical study assessing HEMOBLAST™ Bellows in the U.S.A.
  • European launch

Visit Biom'up website

Find out more about HEMOBLAST™ Bellows

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.